Tweet by Michael “Mike” Albert, MD on Twitter. Combined pharm rx

qcWXgj7w_normal.jpg spacer.png
Michael “Mike” Albert, MD
⁦‪@MichaelAlbertMD‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
The future of obesity treatment is polyagonist anorectic agents combined with metabolic enhancers (mitochondrial uncouplers, leptin analogs, etc.). The right combination of therapy would normalize energy homeostasis and remit obesity in all people.
2/4/23, 2:23 PM

Joseph Thornton

Published by Joseph Thornton MD

Teacher, Clinical Supervisor Clinical Associate Professor, Psychiatry University of Florida Affiliation is for identification only. All content and opinions are my own.

Leave a comment